SYNG Pharmaceuticals
- Biotech or pharma, therapeutic R&D
SYNG is developing a new first-in-class diagnostic test and non-hormonal therapeutic for Endometriosis. Seeking distributors for the endometriosis test (consumer and CLIA) and strategic investors/partners for a diagnostic accompanied non-hormonal therapy.